United Capital Financial Advisors’s Histogen Inc. Common Stock HSTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,999
| Closed | -$20K | – | 1210 |
|
|
2022
Q1 | $20K | Hold |
3,999
| – | – | ﹤0.01% | 1152 |
|
|
2021
Q4 | $26K | Hold |
3,999
| – | – | ﹤0.01% | 1192 |
|
|
2021
Q3 | $61K | Hold |
3,999
| – | – | ﹤0.01% | 1180 |
|
|
2021
Q2 | $87K | Sell |
3,999
-38
| -0.9% | -$788 | ﹤0.01% | 1197 |
|
|
2021
Q1 | $105K | Hold |
4,037
| – | – | ﹤0.01% | 1160 |
|
|
2020
Q4 | $61K | Hold |
4,037
| – | – | ﹤0.01% | 1168 |
|
|
2020
Q3 | $132K | Buy |
4,037
+1,754
| +77% | +$84.5K | ﹤0.01% | 1098 |
|
|
2020
Q2 | $174K | Buy |
2,283
+1,679
| +278% | +$141K | ﹤0.01% | 1113 |
|
|
2020
Q1 | $37K | Hold |
604
| – | – | ﹤0.01% | 1155 |
|
|
2019
Q4 | $48K | Hold |
604
| – | – | ﹤0.01% | 1340 |
|
|
2019
Q3 | $37K | Sell |
604
-273
| -31% | -$17.8K | ﹤0.01% | 1271 |
|
|
2019
Q2 | $46K | Hold |
877
| – | – | ﹤0.01% | 1433 |
|
|
2019
Q1 | $190K | Sell |
877
-1
| -0.1% | -$403 | ﹤0.01% | 1281 |
|
|
2018
Q4 | $304K | Sell |
878
-122
| -12% | -$94.8K | ﹤0.01% | 1057 |
|
|
2018
Q3 | $1.16M | Sell |
1,000
-635
| -39% | -$585K | 0.01% | 737 |
|
|
2018
Q2 | $1.4M | Sell |
1,635
-3
| -0.2% | -$2.49K | 0.01% | 676 |
|
|
2018
Q1 | $1.92M | Buy |
1,638
+63
| +4% | +$69.6K | 0.01% | 601 |
|
|
2017
Q4 | $1.46M | Sell |
1,575
-73
| -4% | -$67.4K | 0.01% | 685 |
|
|
2017
Q3 | $1.81M | Buy |
1,648
+674
| +69% | +$766K | 0.02% | 606 |
|
|
2017
Q2 | $1.12M | Buy |
974
+201
| +26% | +$245K | 0.01% | 736 |
|
|
2017
Q1 | $892K | Hold |
773
| – | – | 0.01% | 771 |
|
|
2016
Q4 | $815K | Buy |
773
+42
| +6% | +$19.1K | 0.01% | 800 |
|
|
2016
Q3 | $292K | Sell |
731
-13
| -2% | -$5.3K | ﹤0.01% | 1084 |
|
|
2016
Q2 | $297K | Hold |
744
| – | – | ﹤0.01% | 1041 |
|
|
2016
Q1 | $318K | Hold |
744
| – | – | ﹤0.01% | 992 |
|
|
2015
Q4 | $428K | Buy |
744
+119
| +19% | +$83.4K | ﹤0.01% | 919 |
|
|
2015
Q3 | $556K | Hold |
625
| – | – | 0.01% | 861 |
|
|
2015
Q2 | $643K | Hold |
625
| – | – | 0.01% | 835 |
|
|
2015
Q1 | $743K | Sell |
625
-56
| -8% | -$71K | 0.01% | 794 |
|
|
2014
Q4 | $954K | Sell |
681
-2
| -0.3% | -$2.89K | 0.01% | 662 |
|
|
2014
Q3 | $836K | Sell |
683
-1
| -0.1% | -$1.44K | 0.01% | 653 |
|
|
2014
Q2 | $1.25M | Buy |
+684
| New | +$914K | 0.02% | 514 |
|
Other funds holding HSTO
HF
United Capital Financial Advisors's HSTO Position: Q2 2022 in Review
United Capital Financial Advisors sold out of Histogen Inc. Common Stock (HSTO) in Q2 2022, closing a stake of 3,999 shares — an estimated $20K sold.
United Capital Financial Advisors first reported a position in HSTO in Q2 2014 and held it in 32 quarters. The position peaked at $1.92M in Q1 2018. 10 funds tracked by Wall St. Rank hold HSTO as of Q2 2022.
- United Capital Financial Advisors reported no remaining Histogen Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
- United Capital Financial Advisors sold 3,999 Histogen Inc. Common Stock shares in Q2 2022, an estimated $20K.
- United Capital Financial Advisors first reported a position in Histogen Inc. Common Stock in Q2 2014 and held it in 32 quarters.
- United Capital Financial Advisors's Histogen Inc. Common Stock position peaked at $1.92M in Q1 2018.
- 10 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2022.
Based on United Capital Financial Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.